Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Other Non-Current Liabilities (2023 - 2025)

INVO Fertility has reported Other Non-Current Liabilities over the past 3 years, most recently at $800000.0 for Q3 2025.

  • Quarterly Other Non-Current Liabilities fell 84.0% to $800000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $800000.0 through Sep 2025, down 84.0% year-over-year, with the annual reading at $5.0 million for FY2024, 0.0% changed from the prior year.
  • Other Non-Current Liabilities was $800000.0 for Q3 2025 at INVO Fertility, down from $1.1 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $7.5 million in Q3 2023 and troughed at $800000.0 in Q3 2025.
  • The 3-year median for Other Non-Current Liabilities is $5.0 million (2023), against an average of $4.1 million.
  • Year-over-year, Other Non-Current Liabilities changed 0.0% in 2024 and then tumbled 84.0% in 2025.
  • A 3-year view of Other Non-Current Liabilities shows it stood at $5.0 million in 2023, then changed by 0.0% to $5.0 million in 2024, then tumbled by 84.0% to $800000.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Other Non-Current Liabilities are $800000.0 (Q3 2025), $1.1 million (Q2 2025), and $2.5 million (Q1 2025).